Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Psychiatry
•
Neuromodulation
How do you manage expectations around response time and durability of benefit in patients starting TMS?
Related Questions
Is there a role for administering IV ketamine immediately after ECT treatments in patients with difficult-to-treat major depressive disorder?
How do you explain and manage transient post-ECT symptoms like irritability, tearfulness, or panic attacks that resolve within a day?
What criteria do you use when deciding whether to start esketamine treatment for patients with treatment resistant MDD who are concomitant CNS depressants?
How do you facilitate access to interventional treatments such as TMS for patients with difficult-to-treat depression who are on Medicaid?
At what point do you consider referring for neuromodulatory treatments (TMS, deep brain stimulation) for treatment refractory-OCD?
When do you refer patients with difficult-to-treat depression for ECT rather than other interventional psychiatric treatments, such as TMS or esketamine?
What is your experience with transcutaneous vagal nerve stimulation for the treatment of anxiety disorders and major depressive disorder?
When do you consider referring adolescents with major depressive disorder for TMS?
How have you gone about implementing TMS in your practice or institution?
How do you use TMS for tinnitus? Where do you target, and what settings on the magnet do you use? Is anyone using either iTBS or cTBS for this!?
